Audio By Carbonatix
The Pfizer/BioNTech vaccine can still target a key mutation that has emerged in two new variants of coronavirus, laboratory studies show.
However, this is only one of many mutations that are found in the new forms of the virus.
So while the study has been welcomed, it is not being seen as definitive scientific evidence about how the vaccine will perform.
Pfizer vaccine 'works' against key variant mutation, study suggests https://t.co/LT31GAj4YM pic.twitter.com/vFnnYhoCoV
— Global Issues Web (@globalissuesweb) January 8, 2021
New variants have been detected in the UK and South Africa.
Both forms of the virus are spreading more quickly and this has raised questions over what level of protection vaccines can offer against them.
The widely held view is that vaccines will still work, but researchers are on the hunt for proof.
The study by the University of Texas focuses on a mutation called N501Y, which as emerged in both new variants.
This is thought to be important because it is in the part of the virus that makes first contact with our body's cells and changes could make it easier to get in and cause an infection.
The researchers created two forms of the virus - one with and one without the mutation - and then bathed those viruses in blood samples taken from 20 patients that had been vaccinated in clinical trials.
The results showed the immune systems of vaccinated patients were able to take out the new mutation.
However, the variant that emerged contain multiple mutations whose combined effects may help the virus evade the immune system.
"The mutation selected is only one of eight in the UK variant, and in fact was not expected to have significant impact alone," Prof Ravi Gupta, from the University of Cambridge said.
Prof Stephen Evans, from the London School of Hygiene & Tropical Medicine, said: "Had the opposite result been found... that would have been bad and very concerning.
"So, yes this is good news, but it does not yet give us total confidence that the Pfizer (or other) vaccines will definitely give protection."
Latest Stories
-
GANRAP is essentially a rebranding of Domestic Gold Purchase Programme – Abu Jinapor
1 minute -
I am tired of being in opposition, my goal is to win in 2028 – Boakye Agyarko
12 minutes -
Ghana’s road maintenance funding gap deepens as only 37% of needs met – World Bank
12 minutes -
Roland Europe Group appoints Opoku Sanaa as Head of Sales, Middle East & Africa
14 minutes -
Sammyflex TV’s Roland Amartey girds up for 2026 Ghana Music Awards UK coverage
26 minutes -
U.S. bank queried payments for Ghana ambassador’s residence renovated by company owned by embassy’s IT officer
44 minutes -
GoldBod to generate US$1.4bn in FX in September
1 hour -
GAF 2026/2027 enlistment opens September 3 for degree holders
1 hour -
Reparatory justice: Mahama announces high-level UN side event in September
1 hour -
Bosome Freho Assembly invests first tranche Common Fund in water and education projects for 19 rural communities
1 hour -
YIPs Ghana honours 5 outstanding students at 2026 Tertiary Achievers Awards
1 hour -
NSMQ 2026: TAMASCO triumphs over St. Hubert and Labone to clinch ticket to the semi-finals
1 hour -
US and Iran trade strikes for first time in weeks
1 hour -
Non-interest banking will not replace conventional banking – Dr Johnson Asiama
1 hour -
Non-interest banking products available to everyone, not just Muslims – Asiama
1 hour